Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Could the metabolome be used to better diagnose C. difficile infections?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
    • International Microbiota Observatory
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Could the metabolome be used to better diagnose C. difficile infections?
Gastroenterology

Could the metabolome be used to better diagnose C. difficile infections?

C difficile
Gastroenterology

Two large families of metabolites (the first are derived from leucine and the second from bile acids) could have the potential to discriminate between a C. difficile infection and an asymptomatic C. difficile colonization.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
    • International Microbiota Observatory
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 19 November 2019
Updated 03 December 2021

 

(sidenote: Clostridioides difficile formerly Clostridium difficile )  infection (CDI) affects about 450,000 people and causes 30,000 deaths per year in the United States. It is responsible for a substantial proportion of deaths attributable to antibiotic-resistant bacteria. CDI arises following the ingestion and adhesion of spores, which then germinate and turn into vegetative forms of the bacterium that colonize and secrete toxins responsible for a wide spectrum of symptoms ranging from diarrhea to life-threatening pseudomembranous colitis. But a carrier may also be completely asymptomatic and CDI may show its pathogenic potential only once antibiotics are taken.

Establishing a list of metabolites

C. difficile is considered as an opportunistic colonizer that might be eradicated by healthy intestinal microbiota. Several metabolic functions are believed to contribute to this eradication. To better understand the link between gut metabolites and CDI in humans, a research team studied the fecal metabolomic profiles of 186 hospitalized patients with symptoms of diarrhea: 62 patients with CDI (positive toxigenic culture and positive enzyme immunoassay), 62 patients with positive toxigenic culture but negative enzyme immunoassay, and 62 matched non-colonized controls (negative toxigenic culture and negative enzyme immunoassay). Fecal metabolites were characterized by gas chromatography.

Two metabolic signatures

Among the 2,463 metabolites detected in the stools, 43 can be used to discriminate between patients with CDI and non colonized controls. Many of them are derived from (sidenote: The Stickland fermentation pathway coupled redox reaction of two amino acids, one playing the role of hydrogen acceptor, the other of hydrogen donor. It occurs in many Clostridium species de Vladar HP. Amino acid fermentation at the origin of the genetic code. Biol Direct. 2012 Feb 10;7:6. ) , in which bacteria, such as C. difficile, use amino acids as substrates. The strongest association found was for a short chain fatty acid resulting from leucine fermentation, which was found in significantly larger quantities in patients with CDI. The team also identified a number of secondary bile acids significantly less abundant in patients with CDI, and derived from the dehydroxylation by gut bacteria of primary bile acids which are synthesized and conjugated by the host. It remains unclear whether these dehydroxylated bile acids are only biomarkers of CDI-negative patients, or if their formation protects them from CDI by inhibiting spore germination, for instance.

Towards a more precise diagnosis?

Eventually, these results could lead to the definition of a specific metabolomic profile for CDI and refine patient diagnosis, by reducing false positives related to inactive spore detection by toxigenic culture, and false negatives caused by the poor sensitivity of the enzyme immunoassay.

Sources

Robinson JI, Weir WH, Crowley JR, et al. Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections. J Clin Invest. 2019 Aug 12;129(9):3792-3806.

Tags
Antibiotics Predictor Clostridium difficile CDI Metabolite

en_view en_sources

    Created 19 November 2019
    Updated 03 December 2021

    About this article

    To know more about this topic.

    Main topic

    C difficile

    Medical practice

    Gastroenterology

    Content type

    News
    Gastroenterology

    Gut Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Rural environment reduces allergic inflammation by modulating the gut microbiota

    COMMENTED ARTICLE - Children’s section By Pr.Emmanuel Ma...

    Find out more

    A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumours

    COMMENTED ARTICLE - ADULTS’ SECTION By Pr. Harry SokolGa...

    Find out more

    Covid-19 & the gut microbiota

    OverviewBy Pr. Tao ZuoSYSU Research Institute of Gastroenterology, Guangdong Institute of Gastroenterology,...

    Find out more

    Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination

    By Pr. Karine ClémentSorbonne University, Inserm, Unité d...

    Find out more

    Highlights of Gut Microbiota for Health - World Summit 2023

    By Dr. Nicolas BenechGastroenterology and hepatology, Microbiota Study Group, Hospices Civils de Lyon, Lyon...

    Find out more

    Everything you need to know about Irritable Bowel Syndrome (IBS)

    Accrediting training, infographics, expert’s video, thematic folder, news… Biocodex Microbiota Institute pr...

    Find out more

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bo...

    Find out more

    Continue reading

    News
    25.10.2022

    Antibiotics: Dr Jekyll and Mr Hyde

    Read the article
    13.09.2023

    Parkinson’s disease: Desulfovibrio bacteria have been found guilty

    Read the article
    18.11.2020

    Gut microbiota signature for cirrhosis

    Read the article
    29.08.2023

    Massive amounts of antibiotic resistance genes found in clouds

    Read the article
    29.08.2023

    Ulcerative colitis: a randomized controlled trial highlights the positive effects of the Mediterranean diet

    Read the article
    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria
    02.06.2022

    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria

    Read the article
    21.03.2022

    Endometriosis and Microbiota: what are the links ?

    Read the article
    Antibiotiques : le mycobiote des nourrissons sous influence
    16.08.2022

    The effect of antibiotics on infant mycobiota

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    Microbiota 17 EN
    Check out our latest magazine
    The first 1000 days of life
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
      • International Microbiota Observatory
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
      • International Microbiota Observatory
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    13.09.2023

    Parkinson’s disease: Desulfovibrio bacteria have been found guilty

    Read the article
    29.08.2023

    Massive amounts of antibiotic resistance genes found in clouds

    Read the article
    29.08.2023

    Ulcerative colitis: a randomized controlled trial highlights the positive effects of the Mediterranean diet

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
      • International Microbiota Observatory
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo